Registration is a 2-step process!
First, click "ADD TO CART" and login.
Then click "ENROLL NOW" to register and gain access to the link that will allow you to complete part 2 of the 2-step registration process.
Wednesday, September 29, 2021 (1:00PM - 1:15PM EDT)
Pre-registration is required to participate.
During this 15-minute webinar, an expert in the field will discuss the use, safety, and efficacy of COVID-19 mRNA vaccines for pregnant persons.
At the completion of this knowledge-based activity, pharmacists will be able to:
- Discuss the use of COVID-19 mRNA vaccines for pregnant persons including safety and efficacy.
Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following webinar is approved for 0.25 contact hour of CPE credit (.025 CEU). The ACPE Universal Activity Number for this activity is 0202-0000-21-351-L06-P.
To obtain credit for completing COVID-19 Vaccines in Pregnant Persons, participants will need to complete the 2-step registration process, attend the live webinar, complete the evaluation questions, and then CLAIM credit. An attendance code and detailed instructions on how to claim credit will be provided during the webinar. Participants need to have a valid pharmacist.com username and password and CPE Monitor account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: September 29, 2021
Expiration date to claim credit for LIVE webinar: November 28, 2021
Development and Support
COVID-19 Vaccines in Pregnant Persons is a live continuing education activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association
This webinar was funded in part by a collaborative agreement with the Centers for Disease Control and Prevention (CDC) — CoAg number 1 NU50CK000576-01-00. The CDC is an agency within the Department of Health and Human Services (HHS). The contents of this resource do not necessarily represent the CDC or HHS, and should not be considered an endorsement by the Federal Government.
Nathaniel Rickles, PharmD, PhD, BCPP and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
The content for the presentation materials within this continuing education activity was reviewed by Mitchel C. Rothholz, RPh, MBA, Chief of Governance & State Affiliates and Executive Director, APhA Foundation, American Pharmacists Association.
There is no fee associated with this activity. *This webinar will be archived and made available as an e-learning activity within 1 week after the live offering has been presented. The archived webinar (home-study) will be available at no cost to APhA members and nonmembers.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
COVID-19 Vaccines in Pregnant Persons
|Date||9/29/2021 1:00:00 PM|
|Address||2215 Constitution Ave, NW|
|City||Washington||State||District of Columbia||Zip Code||20037|